作者:Keduo Qian、Sang-Yong Kim、Hsin-Yi Hung、Li Huang、Chin-Ho Chen、Kuo-Hsiung Lee
DOI:10.1016/j.bmcl.2011.07.072
日期:2011.10
study, 22 new betulinic acid (BA) derivatives were synthesized and tested for their inhibition of the chymotrypsin-like activity of 20S proteasome. From the SAR study, we concluded that the C-3 and C-30 positions are the pharmacophores for increasing the proteasome inhibition effects, and larger lipophilic or aromatic side chains are favored at these positions. Among the BA derivatives tested, compounds
在这项研究中,合成了 22 种新的桦木酸 (BA) 衍生物并测试了它们对 20S 蛋白酶体的胰凝乳蛋白酶样活性的抑制作用。从 SAR 研究中,我们得出结论,C-3 和 C-30 位置是增加蛋白酶体抑制作用的药效团,并且在这些位置有利于较大的亲脂或芳香侧链。在测试的BA衍生物,化合物13,20,和21显示出最好的蛋白酶体抑制活性,IC 50个分别1.42,1.56,和1.80μM,的值,它是三至四倍比蛋白酶体抑制控制LLM-F更有效和乳胱氨酸。